Murillo Perez, C. F., Harms, M. H., Lindor, K. D., van Buuren, H. R., Hirschfield, G. M., Corpechot, C., van der Meer, A. J., Feld, J. J., Gulamhusein, A., Lammers, W. J., Ponsioen, C. Y., Carbone, M., Mason, A. L., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Floreani, A., Lleo, A., Nevens, F., Kowdley, K. V., Bruns, T., Dalekos, G. N., Gatselis, N. K., Thorburn, D., Trivedi, P. J., Verhelst, X., Parés, A., Janssen, H. L., Hansen, B. E., & , (2020). goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. American journal of gastroenterology, 115, 1066–1074. http://access.bl.uk/ark:/81055/vdc_100169170735.0x000064